2019

Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis.

29 Apr, 2019

Authors: European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord Published in: HIV Med. 2019;20(5):291-307 Objectives Combination neonatal prophylaxis (CNP) is recommended in high‐risk situations for the prevention of mother‐to‐child…
Read More

Prevalence and clinical outcomes of poor immune response despite virologically suppressive antiretroviral therapy among children and adolescents with HIV in Europe and Thailand: cohort study

29 Apr, 2019

Authors: Collins IJ; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord Published in: Clin Infect Dis. 2019; 28. pii: ciz253. doi: 10.1093/cid/ciz253. [Epub ahead of print] Background In…
Read More

Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes

26 Mar, 2019

Authors: European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group Published in: Aids. 2019;33(2):295-304. Objectives The aim of this study was to investigate whether specific nucleoside reverse transcriptase inhibitor (NRTI) backbones are…
Read More

Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy A Multicohort Analysis

26 Mar, 2019

Authors: Martinez de Tejada B; European Pregnancy and Paediatric HIV Cohort Collaboration Study Group. Published in: J Acquir Immune Defic Syndr. 2019;80(3):316-324   Background To investigate the association between efavirenz (EFV)…
Read More

Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand

25 Mar, 2019

Authors: Chan MK, Goodall R, Judd A, et al. Published in: Aids. 2019; 33(7):1155-1165 Objective To identify predictors of faster time to virological suppression among infants starting combination antiretroviral therapy (cART) early in infancy. Design Cohort study of…
Read More